Estamos realizando la búsqueda. Por favor, espere...
1583
37
170
29187
4419
2601
347
390
Abstract: Introduction: Interleukin-9 (IL-9) has been cast as a player in autoimmunity, but its role in liver transplantation remains to be clarified. The aim of our study was to investigate the time course of IL-9 serum levels during hepatic allograft rejection. Methods: IL-9 serum levels were determined in 34 healthy subjects and 50 hepatic transplant recipients. The patients were divided into two groups: group I was composed of 15 patients with acute rejection episodes, and group II, 35 patients free of this problem. Samples were collected on days 1 and 7 after liver transplantation and on the day of liver biopsy. Results: The concentrations of IL-9 were similar in the rejection and nonrejection groups over the entire postoperative period. The whole transplant group, including those with stable graft function, showed higher IL-9 serum levels than the controls at all times after liver transplantation. Conclusions: These preliminary results suggest a lack of participation of IL-9 in human liver allograft rejection.
Fuente: Transplantation Proceedings, 2012, 44(6), 1533-1535
Editorial: Elsevier
Año de publicación: 2012
Nº de páginas: 3
Tipo de publicación: Artículo de Revista
DOI: 10.1016/j.transproceed.2012.05.013
ISSN: 0041-1345,1873-2623
Url de la publicación: https://doi.org/10.1016/j.transproceed.2012.05.013
Leer publicación
EMILIO FABREGA GARCIA
MARCOS LOPEZ HOYOS
DAVID SAN SEGUNDO ARRIBAS
FERNANDO CASAFONT MORENCOS
ANGEL MIESES, M.
SAMPEDRO, BLANCA
FERNANDO PONS ROMERO
Volver